Select Publications

Journal articles

Yulyaningsih E; Zhang L; Herzog H; Sainsbury-Salis A, 2011, 'NPY receptors as potential targets for anti-obesity drug development', British Journal of Pharmacology, 163, pp. 1170 - 1202, http://dx.doi.org/10.1111/j.1476-5381.2011.01363.x

Verma D; Tasan RO; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a3

Zhang X; Herzog H; Song J; Wang XL; Fan C; Guo H, 2011, 'Response properties of the electrosensory neurons in hindbrain of the white sturgeon, Acipenser transmontanus', Neurosci Bull, 27, pp. 422 - 429

Acosta AC; Hurtado MD; Gorbatyuk OS; Duncan D; Aslanidi GV; Campbell-thompson ML; Zhang L; Herzog H; Voutetakis A; Baum BJ; Zolotukhin S, 2011, 'Salivary PYY: A putative bypass to satiety', PLoS One, 5, pp. Article no. e26137, http://dx.doi.org/10.1371/journal.pone.0026137

Painsipp E; Herzog H; Sperk G; Holzer P, 2011, 'Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide y', British Journal of Pharmacology, 163, pp. 1302 - 1314, http://dx.doi.org/10.1111/j.1476-5381.2011.01326.x

Zhang L; Bijker MS; Herzog H, 2011, 'The neuropeptide y system: Pathophysiological and therapeutic implications in obesity and cancer', Pharmacology and Therapeutics, 131, pp. 91 - 113, http://dx.doi.org/10.1016/j.pharmthera.2011.03.011

Macia L; Rao PT; Wheway J; Sierro F; Mackay F; Herzog H, 2011, 'Y1 signalling has a critical role in allergic airway inflammation', Immunology and Cell Biology, 89, pp. 882 - 888, http://dx.doi.org/10.1038/icb.2011.6

Mountford J; Zhang L; Herzog H; Thompson P, 2010, 'Synthesis of Neuropeptide Y analogues as PET imaging agents', JOURNAL OF PEPTIDE SCIENCE, 16, pp. 89 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281610800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Acoustic startle response and sensorimotor gating in a genetic mouse model for the NPY Y1 receptor.', Neuropeptides, 44, pp. 233 - 239

Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler S; Stehrer B; Yulyaningsih E; Lin S; Shi Y; Baldock PA; Herzog H; Sainsbury-Salis A, 2010, 'Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation', Diabetes Obesity and Metabolism, 12, pp. 591 - 603

Lin ED; Lin S; Aljanova A; During M; Herzog H, 2010, 'Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice', European Neuropsychopharmacology, 20, pp. 164 - 175

Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A, 2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013

Painsipp E; Sperk G; Herzog H; Holzer P, 2010, 'Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice', Journal of Psychopharmacology, 24, pp. 1541-9, http://dx.doi.org/10.1177/0269881109104851

Schwarzer C; Lutsch C; Schunk E; Kastenberger I; Herzog H, 2010, 'Endogenous dynorphin in emotional control and stress response revisited', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a32

Painsipp E; Herzog H; Holzer P, 2010, 'Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge', Journal of Psychopharmacology, 24, pp. 1551 - 1560

Wong I; Baldock PA; Herzog H, 2010, 'Gastrointestinal peptides and bone health', Current Opinion in Endocrinology and Diabetes, 17, pp. 44 - 50

Yulyaningsih E; Macia L; Driesler F; Herzog H; Sainsbury A, 2010, 'Lack of Y6 receptor signaling in mice results in a lean phenotype on a chow diet but exacerbated high fat diet-induced obesity', Obesity Research & Clinical Practice, 4, pp. S65 - S65, http://dx.doi.org/10.1016/j.orcp.2010.09.127

Prior LJ; Purtell L; Duke S; Campbell L; Sainsbury A; Herzog H, 2010, 'Mouse model of Prader–Willi syndrome: The role of SNORD116 in the regulation of energy homeostasis', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.012

Zengin A; Zhang L; Herzog H; Baldock PA; Sainsbury-Salis A, 2010, 'Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat', Trends in Endocrinology and Metabolism, 21, pp. 411 - 418

Tasan RO; Verma D; Herzog H; Sperk G, 2010, 'Neuropeptide Y in the basolateral amygdala modulates the acquisition of conditioned fear', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a33

Shi Y; Lin S; Wong I; Baldock PA; Aljanova A; Enriquez RF; Castillo L; Mitchell NF; Ye J; Zhang L; Macia L; Yulyaningsih E; Nguyen AD; Riepler S; Herzog H; Sainsbury-Salis A, 2010, 'NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice', PLoS One, 5, pp. e11361, http://dx.doi.org/10.1371/journal.pone.0011361

Cox H; Tough IR; Zhang L; Woolston A-M; Nguyen AD; Sainsbury-Salis A; Herzog H, 2010, 'Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses', Cell Metabolism, 11, pp. 532 - 542, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20519124

Zhang L; Macia L; Turner N; Enriquez RF; Nguyen AD; Lin S; Lee NJ; Shi Y; Yulyaningsih E; Slack K; Baldock PA; Herzog H; Sainsbury-Salis A, 2010, 'Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion', International journal of obesity, 34, pp. 357 - 373, http://dx.doi.org/10.1038/ijo.2009.232

Viardot AC; Sze L; Purtell L; Sainsbury-Salis A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV, 2010, 'Prader-willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance', Journal of Clinical Endocrinology and Metabolism, 95, pp. 3392 - 3399

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency', Behavioural Brain Research, 207, pp. 434 - 440

Tasan R; Nguyen NK; Weger S; Sartori S; Singewald N; Heilbronn R; Herzog H; Sperk G, 2010, 'The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression', Journal of Neuroscience, 30, pp. 6282 - 6290

Sainsbury-Salis A; Shi Y; Zhang L; Aljanova A; Lin Z; Nguyen AD; Herzog H; Lin S, 2010, 'Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways', Neuropeptides, 44, pp. 261 - 268, http://dx.doi.org/10.1016/j.npep.2010.01.001

Allison SJ; Baldock PA; Enriquez R; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H, 2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304

Lin S; Shi Y; Yulyaningsih E; Aljanova A; Macia L; Nguyen A; Lin ED; Zhang L; During M; Herzog H; Sainsbury A, 2009, 'Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice', PLoS One, 4, pp. 8488, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20041129

Nguyen NK; Sartori S; Herzog H; Tasan R; Sperk G; Singewald N, 2009, 'Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice', Synapse, 63, pp. 236 - 246

Schwarzer C; Wittmann W; Schunk E; Kastenberger I; Gaburro S; Singewald N; Herzog H, 2009, 'Endogenous dynorphin in emotional control and stress response', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a39

Edelsbrunner M; Painsipp E; Herzog H; Holzer P, 2009, 'Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake', Neuropeptides, 43, pp. 491 - 497, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19781771

Edelsbrunner M; Herzog H; Holzer P, 2009, 'Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner', Behavioural Brain Research, 203, pp. 97 - 107

Tasan R; Lin SC; Hetzenauer A; Singewald N; Herzog H; Sperk G, 2009, 'Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice', Neuroscience, 158, pp. 1717 - 1730

Kastenberger I; Schunk E; Herzog H; Schwarzer C, 2009, 'Involvement of dynorphin in anxiogenic effects of estrogen', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a9

Baldock PA; Lee NJ; Driessler F; Lin S; Allison SJ; Stehrer B; Enriquez R; Zhang L; Lin E; Wong I; Mcdonald M; During M; Pierroz D; Slack K; Shi Y; Yulyaningsih E; Aljanova A; Little DG; Ferrari S; Sainsbury-Salis A; Eisman JA; Herzog H, 2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight', PLoS Clinical Trials, 4, pp. e8415 - e

Lee NJ; Herzog H, 2009, 'NPY regulation of bone remodelling', Neuropeptides, 43, pp. 457 - 463

Teixeira L; Sousa D; Nunes A; Sousa M; Herzog H; Lamghari M, 2009, 'NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors', Journal of Cellular Biochemistry, 107, pp. 908 - 916

Sousa D; Herzog H; Lamghari M, 2009, 'NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target', Current Drug Targets, 10, pp. 9 - 19

Wittmann W; Schunk E; Rosskothen I; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2009, 'Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone', Neuropsychopharmacology, 34, pp. 775 - 785

Painsipp E; Herzog H; Holzer P, 2009, 'The gut-mood axis: a novel role of the gut hormone peptide YY on emotional-affective behaviour in mice', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a13

Verma D; Tasan RO; Herzog H; Sperk G, 2009, 'The role of NPY in expression and extinction of conditioned fear', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a33

Tilan JU; Everhart LM; Abe K; Kitlinska J; Herzog H; Zukowska Z, 2008, 'Megakaryocyte/platelet-derived Neuropeptide Y (NPY), in addition to neuronal, is essential for ischemic revascularization in rodents', FASEB JOURNAL, 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208467808113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Viardot AC; Heilbronn L; Herzog H; Gregersen S; Campbell LV, 2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24

Schunk E; Rosskothen I; Wittmann W; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2008, 'Behavioural characterization of prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a5

Karl T; Duffy L; Herzog H, 2008, 'Behavioural profile of a new mouse model for NPY deficiency', European Journal of Neuroscience, 28, pp. 173 - 180

Wong I; Zengin A; Herzog H; Baldock P, 2008, 'Central regulation of bone mass', Seminars in Cell and Developmental Biology, 19, pp. 452 - 458

Baldock PA; Wong I; Mcdonald M; Enriquez R; Scwarzer C; Little DG; Sainsbury-Salis A; Herzog H; Eisman JA, 2008, 'Endorphins regulate bone homeostasis by actions through dynorphin', Bone, 42, pp. S43 - S44, http://dx.doi.org/10.1016/j.bone.2007.12.070

Painsipp E; Herzog H; Holzer P, 2008, 'Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice', Neuropharmacology, 55, pp. 117 - 126

Tasan RO; Lin S; Hetzenauer A; Singewald N; Herzog H; Sperk G, 2008, 'Increased novelty-induced motor activity and reduced depression-like behavior in NPY Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a17


Back to profile page